Eam Investors, LLC Global Blood Therapeutics, Inc. Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $1.13 Million - $1.89 Million	-23,126 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$41.72 - $87.2 $332,049 - $694,024	-7,959 Reduced 25.6%	23,126 $1.18 Million
Q4 2019 Feb 11, 2020	BUY	$45.7 - $81.86 $1.42 Million - $2.54 Million	31,085 New	31,085 $2.47 Million
Q2 2018 Aug 03, 2018	SELL	$38.7 - $50.15 $1.91 Million - $2.47 Million	-49,311 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $152,499 - $253,780	3,851 Added 8.47%	49,311 $2.38 Million
Q4 2017 Feb 12, 2018	SELL	$29.7 - $45.7 $697,979 - $1.07 Million	-23,501 Reduced 34.08%	45,460 $1.79 Million
Q3 2017 Nov 08, 2017	BUY	$25.1 - $31.05 $1.73 Million - $2.14 Million	68,961	68,961 $2.14 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.